Transcatheter repair of tricuspid regurgitation with MitraClip

Prog Cardiovasc Dis. 2019 Nov-Dec;62(6):488-492. doi: 10.1016/j.pcad.2019.10.001. Epub 2019 Oct 23.

Abstract

Transcatheter therapy with the MitraClip system (Abbott Structural, Menlo Park, CA) is the most commonly used transcatheter therapy for patients with tricuspid regurgitation, with over 1000 cases performed worldwide. The procedure is an off-label approach that requires meticulous attention to anatomical features obtained via comprehensive echocardiography and, in some cases, using cardiac computed tomography. Herein, we describe patient selection, procedural performance, and clinical outcomes of this therapy.

Keywords: MitraClip; Outcome; Transcatheter; Tricuspid regurgitation.

Publication types

  • Review

MeSH terms

  • Cardiac Catheterization / methods
  • Echocardiography / methods*
  • Equipment Design
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Heart Valve Prosthesis Implantation* / instrumentation
  • Heart Valve Prosthesis Implantation* / methods
  • Heart Valve Prosthesis*
  • Humans
  • Patient Selection
  • Severity of Illness Index
  • Treatment Outcome
  • Tricuspid Valve Insufficiency* / diagnosis
  • Tricuspid Valve Insufficiency* / surgery
  • Tricuspid Valve* / anatomy & histology
  • Tricuspid Valve* / diagnostic imaging
  • Tricuspid Valve* / surgery